Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By stimulating these https://heidiljss441671.humor-blog.com/35047584/retatrutide-a-promising-new-treatment-for-obesity